pyroxamide has been researched along with alpha-aminopyridine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agus, DB; Breslow, R; Butler, LM; Cordon-Cardo, C; Drobnjak, M; Higgins, B; Kutko, MC; LaQuaglia, MP; Marks, PA; Richon, VM; Rifkind, RA; Scher, HI; Tolentino, TR; Webb, Y | 1 |
| Daud, A; Munster, P; Spriggs, DR | 1 |
| Eckert, C; Einsiedel, HG; Fichtner, I; Henze, G; Kawan, L; Seeger, K; Witt, O | 1 |
| Chen, KM; Datta, I; Divine, G; Garcia-Rodriguez, L; Jones, L; Worsham, MJ | 1 |
| Borre, M; Cieza-Borrella, C; Dagnaes-Hansen, F; Eeles, R; Haldrup, J; Hedensted, S; Jakobsson, ME; Kote-Jarai, Z; Norgaard, M; Olsen, JV; Riedel, M; Sorensen, KD; Strand, SH; Thomsen, M; Ulhoi, BP | 1 |
1 review(s) available for pyroxamide and alpha-aminopyridine
| Article | Year |
|---|---|
New drugs in gynecologic cancer.
Topics: Aminopyridines; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Boronic Acids; Bortezomib; Cisplatin; Female; Gefitinib; Genital Neoplasms, Female; Humans; Hydroxamic Acids; Lactams, Macrocyclic; Organoplatinum Compounds; Paclitaxel; Protein-Tyrosine Kinases; Pyrazines; Quinazolines; Trastuzumab | 2001 |
4 other study(ies) available for pyroxamide and alpha-aminopyridine
| Article | Year |
|---|---|
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase.
Topics: Acetylation; Aminopyridines; Animals; Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Line, Transformed; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Disease Models, Animal; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Disease Models, Animal; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Hydroxamic Acids; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Heterologous | 2006 |
Causal network analysis of head and neck keloid tissue identifies potential master regulators.
Topics: Aminopyridines; Case-Control Studies; CpG Islands; Cyclic GMP-Dependent Protein Kinase Type II; DNA Methylation; Enkephalins; Gene Expression; Gene Expression Profiling; Genes, Regulator; Head; Humans; Hydroxamic Acids; Keloid; Neck; Prospective Studies; Protein Precursors; Skin; Triglycerides | 2016 |
FRMD6 has tumor suppressor functions in prostate cancer.
Topics: Aged; Aminopyridines; Animals; Cell Proliferation; Cytoskeletal Proteins; DNA Methylation; Down-Regulation; Hippo Signaling Pathway; Humans; Hydroxamic Acids; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Middle Aged; Prognosis; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Serine-Threonine Kinases; PTEN Phosphohydrolase; Tumor Suppressor Proteins | 2021 |